Vitamin B12 Deficiency: Why the Guidelines Are Too Low (2026)

Eight clients in a row. Eight suboptimal vitamin B12 levels. Not “keep an eye on it” — genuinely low, using the same cutoff that neurologists in Europe and Japan have relied on for years.

And it isn’t just a streak. Every single client whose B12 I’ve tested over the last few months has come back with suboptimal status. Not most of them. All of them.

If I ran those same panels through a standard U.S. lab and read them the way most conventional providers are trained to, not one of those clients would have flagged as deficient. Their B12 would have come back “normal.”

And that’s the part that keeps me up at night: this isn’t rare. I am seeing it constantly. And the standard workup most people get isn’t built to catch it.

The Cutoff You’re Being Measured Against Matters More Than You Think

Here’s something most people never hear from their doctor: there is no single, universal number that defines vitamin B12 deficiency. The threshold depends entirely on which country wrote the guideline your lab happens to be using.

In the United States, a B12 level is typically flagged as deficient only when it drops below roughly 200 pg/mL (about 148 pmol/L). European neurological guidelines — including work from the European Federation of Neurological Societies — and Japanese clinical standards use a cutoff closer to 500 pg/mL (roughly 370 pmol/L).

That higher threshold reflects research showing that functional deficiency and neurological symptoms can show up well before a person crosses the U.S. line into “abnormal.”

That is not a small gap. That is a 300-point gray zone where a person can be functionally, symptomatically deficient in B12 and still be told their labs are fine.

This Isn’t a Technicality — It’s Where Symptoms Actually Show Up

The U.S. cutoff was calibrated to catch frank megaloblastic anemia — the late-stage, unmistakable presentation of B12 deficiency. It was never designed to catch the earlier, quieter phase where someone has brain fog, fatigue, numbness or tingling in the extremities, mood changes, or memory issues, while their bloodwork still says “within range.”

But the neurological literature is clear that nerve-level symptoms can appear well above 200 pg/mL. That’s exactly why the European and Japanese thresholds sit so much higher — they were set using evidence of when symptoms and functional markers like methylmalonic acid (MMA) actually start climbing, not just when a person becomes anemic.

So when I see a B12 level of 320, or 280, or 410 pg/mL, I’m not reassured. I’m paying attention. A U.S. lab will print that result in black text with no flag next to it. I read the same number and see a person who is very likely running on an inadequate B12 supply, with symptoms to match, and no paperwork acknowledging it.

This isn’t just a European vs. U.S. framing issue, either — it holds up in the research on where symptoms actually start. Levels below 475 pg/mL have already been associated with measurable nerve damage, and levels below 550 pg/mL have been linked to low B12 in cerebrospinal fluid.

And this isn’t new science. Back in 1992, researchers screening older outpatients in the Journal of the American Geriatrics Society found that people with “low normal” B12 between 201 and 300 pg/mL had elevated metabolic markers of deficiency (MMA and homocysteine) at nearly the same rate as people below 200 — 56% versus 62% — and those markers dropped once they were treated with B12. The authors concluded that serum B12 on its own was an insensitive screening tool (PubMed).

Four years later, the same journal published a case that makes this point even more vividly. An 85-year-old man — independent, still driving and working — had developed memory lapses and lethargy over two years. His B12 came back at 368 pg/mL, confirmed on repeat testing, and squarely “normal” by U.S. standards. His cognitive screening score was 21 out of 30, and he had lost vibration sense in both ankles, an early sign of nerve involvement.

His clinicians treated him for B12 deficiency anyway, with intramuscular B12 injections. By the fifth injection, his cognitive score had climbed to 27 out of 30, his lethargy and slowed thinking were gone, and sensation in his feet was returning. The same clinic reported four earlier patients with reversible, B12-related dementia whose levels sat between 350 and 400 pg/mL — all “normal” on paper (J Am Geriatr Soc, 1996).

The authors went straight at the cutoff itself: the U.S. lower limit of 200 pg/mL is based on blood (hematological) criteria, while Japan and parts of Europe set the floor at 500–550 pg/mL using neurological criteria. They called for the U.S. range to be reassessed on neurological grounds. That was 1996.

Thirty years later, U.S. labs are still flagging deficiency at the same cutoff those researchers were questioning — and I’m watching the consequences show up in client after client.

I go through that data in more detail in my post on the B12–weight loss connection — optimal levels run considerably higher than the standard reference range most labs are still using.

Why I Treat a Low B12 as a Red Flag for Everything Else

Here’s the piece that doesn’t get talked about enough: B12 rarely travels alone. In my clinical experience, a B12 level in that gray zone is almost never an isolated finding.

It’s usually a signal — of poor absorption (often from low stomach acid, gut inflammation, or SIBO), of a diet gap, of methylation issues, or of years of quiet undertreatment that has let other nutrient stores erode right alongside it. Folate, vitamin B6, iron, vitamin D, zinc, and magnesium show up short far more often than chance would predict once B12 is already low.

That’s the pattern that worries me most. A “borderline” B12 on a U.S. panel isn’t just a B12 problem. It’s often the one thread a conventional workup happened to pull on — and there’s usually more underneath it that never gets tested because nothing prompted a deeper look.

So Why Is This Happening Now?

I’ve been in clinical practice for 25 years, and I want to be direct about something: this is new. Twenty years ago, I simply was not seeing B12 deficiency at anywhere near this frequency. It was the occasional case — not eight clients in a row, and certainly not every client I tested over a span of months.

That shift matters. This isn’t a static, always-been-this-way problem — it’s an accelerating one. Something has changed in the last two decades that’s driving B12 status down across a much wider swath of the population than the old “rare condition” framing accounts for.

Some of what’s driving this fits the story doctors already know. Low stomach acid is far more common than most people realize, and it’s the very first step in the B12 absorption chain — without adequate acid, B12 never gets properly released from food proteins in the first place.

Acid-suppressing medications compound this directly. Omeprazole and pantoprazole, two of the most widely prescribed proton pump inhibitors for reflux and GERD, work by shutting down the stomach acid production that B12 absorption depends on. Millions of people take one of these long-term without anyone connecting it back to their B12 status.

Chronic inflammation plays a role too. Conditions like SIBO, leaky gut, and autoimmune gut disorders damage the intestinal lining and interfere with the intrinsic-factor-mediated absorption that happens further down in the ileum. If SIBO is part of the picture, addressing the bacterial overgrowth itself — not just supplementing around it — matters for absorption to actually normalize; I cover the right probiotic strains to use (and which ones to avoid) in my SIBO probiotics guide. A diet quality problem compounds all of this — heavily processed, nutrient-poor eating patterns simply don’t supply much B12 to begin with, since animal foods are essentially the only natural source.

Vegetarians and vegans are the population everyone already expects to run low, for exactly that reason. That part isn’t surprising.

Here’s what genuinely alarms me: I am seeing this constantly in omnivores. People who eat meat regularly, who by every conventional assumption should have plenty of B12 coming in through their diet, are showing up with the same deficiency pattern as my vegetarian and vegan clients.

That tells me diet alone isn’t the story anymore. Something downstream of intake — absorption, inflammation, medication exposure, gut health — is increasingly the bottleneck, and it’s happening in people nobody would think to screen.

Standard Panels Aren’t Built to Catch This

This is the part that should genuinely alarm people: a routine annual physical in the U.S. does not automatically include a B12 test. It’s not part of a standard CBC or metabolic panel. It gets ordered only if a provider specifically suspects deficiency — usually after anemia has already developed, or after a patient has been symptomatic long enough to push for it themselves.

Vitamin B12 deficiency used to be treated as a rare condition, seen mostly in strict vegans, older adults with absorption issues, or people with diagnosed pernicious anemia. That assumption is exactly why it isn’t screened for more broadly — and it’s exactly why I think that assumption is outdated.

In my practice, it is not rare. It is one of the most common findings I see, and I am specifically the kind of provider who orders the test that a general practice visit usually skips.

I also think there’s a very current reason the deficiency rate I’m seeing has climbed: GLP-1 medications. Semaglutide and tirzepatide (Ozempic, Wegovy, Mounjaro, Zepbound) slow gastric emptying, reduce stomach acid activity, and cut overall food intake by 20–40% — all three of which are required for normal B12 absorption.

Combine a GLP-1 medication with metformin, which independently blocks B12 absorption in the ileum, and deficiency risk climbs further. I break down the absorption mechanics and the metformin interaction more fully in my B12 and weight loss article. With how widely these medications are prescribed right now, I’d expect the undiagnosed-deficiency problem to get worse before it gets better — not better.

The result is a deficiency that can sit undiagnosed for years, doing slow damage to nerve function and cognition the entire time, simply because nobody ran the panel or because the number that came back didn’t cross a threshold that was never designed to catch it early.

Don’t Correct It With B12 Alone

If you and your provider confirm a low or borderline B12 level, resist the urge to grab a B12-only supplement off the shelf. In my clinical experience, most clients don’t fully respond to isolated B12 — and that’s not a coincidence.

The B vitamins function as an interdependent family, not as standalone nutrients. I go into this in more depth in my guide to the energizing vitamins and minerals, but the short version is this: taking one B vitamin in isolation, B12 included, can mask a deficiency in one of the others rather than resolve the underlying problem.

A good B-complex, or a high-quality multivitamin that includes the full B family, is almost always a better starting point than a single-nutrient B12 supplement.

Form matters here too. Cyanocobalamin — the cheap, synthetic form of B12 used in most drugstore supplements and fortified foods — is not what I reach for with clients. It converts less efficiently in the body than the natural, bioactive forms, methylcobalamin and adenosylcobalamin. I break down the full natural-vs-synthetic comparison, including which forms to look for on a label, in my post on synthetic vitamins to avoid.

There’s a heart-health angle here as well that reinforces why B12 shouldn’t be corrected in a vacuum. B12 and folate work together to help metabolize homocysteine, a compound that damages arterial walls when it accumulates.

A large meta-analysis found that supplemental folic acid reduced cardiovascular disease and stroke risk (PubMed) — but that benefit depends on adequate B12 and natural folate working in tandem, not on either nutrient alone. I cover the full homocysteine picture, along with the rest of the nutrients that matter for cardiovascular health, in my heart health supplement guide.

If you’re shopping for a B-complex or multivitamin to correct a low B12, don’t just grab whatever’s cheapest at the pharmacy. Look for GMP certification, activated/natural forms (methylcobalamin or adenosylcobalamin rather than cyanocobalamin, methylfolate rather than folic acid), and whole-food sourcing where possible.

I lay out the full buying criteria, along with the brands that consistently meet them, in my natural vitamin brands guide.

That said, a B-complex alone isn’t always enough on its own to correct a true deficiency. In my clinical experience, once someone is genuinely low, they often need a B-complex and a high-dose B12 supplement given together — the complex to support the rest of the B family and prevent the masking effect described above, and a concentrated B12 dose to actually rebuild depleted stores.

When oral B12 works, it usually takes at least 1 mg (1,000 mcg) daily to meaningfully move the needle, which is well above what most standard multivitamins provide on their own. Even at that dose, some people don’t respond well to oral B12 alone, so retesting matters.

Form and delivery matter for repletion speed, too. Sublingual B12 — a tablet or liquid held under the tongue rather than swallowed — bypasses some of the digestive absorption barriers I mentioned earlier and tends to replete levels faster than standard capsules for many clients.

For people with more significant deficiency, malabsorption issues, or a slow response to oral supplementation, B12 injections may be necessary to correct levels in a reasonable timeframe. This is worth discussing directly with your provider rather than guessing at the right form or dose on your own.

Research backs this up, even when the brain is the target. In a study of 14 patients with dementia, every one of them had serum B12 within that study’s normal range of 500–1,300 pg/mL — a floor more than double the U.S. cutoff. Researchers measured B12 in both the blood and the cerebrospinal fluid, the fluid surrounding the brain and spinal cord.

Two milligrams a day of oral methylcobalamin, on its own, didn’t significantly raise B12 in either the blood or the spinal fluid. But when the same oral dose was combined with daily intramuscular injections of 500 mcg, levels rose markedly in both (PubMed). That’s a small study in an older, impaired group, but it’s a clear reminder that a good oral dose doesn’t guarantee B12 is actually reaching the nervous system.

A High B12 Level Isn’t a Sign of Toxicity

Once clients start repleting, their numbers often climb well above 1,000 pg/mL — and that’s usually when someone, somewhere, tells them their B12 is “too high.” I want to be clear about this: a high B12 level from supplementing is not B12 toxicity.

B12 is a water-soluble vitamin with an exceptionally low potential for harm. The Food and Nutrition Board, which sets the official nutrient intake standards in the U.S., never established a tolerable upper intake level for B12 because no adverse effects have been tied to high intakes from food or supplements. Even at large doses, it’s considered safe, partly because the body absorbs only a fraction of a high oral dose and doesn’t hold on to the excess (NIH Office of Dietary Supplements).

That’s the opposite of fat-soluble vitamins like A and D, which build up in tissue and can reach truly toxic levels. A high serum B12 in someone taking a supplement or getting injections simply reflects what they’re taking. It’s the expected result of repletion, not a warning sign.

Where a high level does deserve attention is when someone isn’t supplementing at all. Research on elevated B12 shows that an unexplained high level is usually driven by an underlying condition — liver disease, kidney disease, or certain blood disorders and cancers — that raises B12 binding proteins in the blood or releases B12 from storage in the liver (PubMed). In those cases, the B12 itself isn’t doing harm. It’s a marker pointing to something else worth investigating.

So the context matters: high and supplementing is expected. High and not supplementing is a reason to look further — not a reason to fear B12.

What I’d Ask, If I Were You

I’m not writing this to tell you that you’re deficient. I’m writing this because I think far more people are walking around with a real, functional B12 problem than conventional guidelines currently acknowledge — and most of them have no idea, because their labs technically say “normal.”

If you have unexplained fatigue, brain fog, tingling or numbness, mood changes, or memory issues that haven’t been fully explained, a B12 level in the 200–500 pg/mL range deserves a second look, not a dismissal. Ask for the number itself, not just the flag next to it. Ask whether MMA or homocysteine has been checked to confirm functional status.

And if you’re already supplementing on your own without ever having tested, know that guessing is exactly what gets people into trouble in the other direction too.

This is the whole reason I built my practice around test not guess. A number on a page is only useful if someone is willing to interpret it against the right standard — and increasingly, I don’t think the U.S. standard is the right one.

Frequently Asked Questions

What is considered a low vitamin B12 level?
In the United States, B12 is typically flagged as deficient below about 200 pg/mL (148 pmol/L). European neurological guidelines and Japanese clinical standards use a higher threshold of about 500 pg/mL (370 pmol/L), based on evidence that neurological symptoms and functional deficiency can appear well above the U.S. cutoff.

Can I be B12 deficient with “normal” labs?
Yes. A B12 level between 200 and 500 pg/mL can read as normal on a standard U.S. panel while still reflecting functional deficiency and neurological symptoms, according to the higher thresholds used in European and Japanese guidelines. Testing methylmalonic acid (MMA) or homocysteine can help confirm functional status when the serum B12 number is in that gray zone.

Does a routine physical test for vitamin B12?
Not automatically. B12 is not part of a standard CBC or metabolic panel and is typically only ordered if a provider specifically suspects deficiency, often after symptoms or anemia have already developed.

Why does a low B12 level matter beyond B12 itself?
In clinical practice, a low or borderline B12 level often signals broader nutrient depletion or absorption issues, since deficiencies rarely occur in isolation. It’s frequently a sign that other levels — including folate, vitamin B6, iron, vitamin D, and magnesium — are worth investigating as well.

What causes low vitamin B12, and can it happen to meat-eaters?
Common causes include low stomach acid, acid-suppressing medications like omeprazole and pantoprazole, chronic gut inflammation (SIBO, leaky gut, autoimmune conditions), poor-quality or ultra-processed diets, and vegetarian or vegan diets. Yes — omnivores can and do become B12 deficient, since absorption problems, inflammation, and medication use can lower B12 status regardless of how much meat or animal protein someone eats.

Should I take a B12 supplement by itself?
Generally, no. Taking B12 in isolation can mask a deficiency in one of the other B vitamins rather than resolve the underlying problem, since the B vitamins function interdependently. A high-quality B-complex or multivitamin that includes the full B family, using natural forms like methylcobalamin or adenosylcobalamin rather than synthetic cyanocobalamin, is generally a better starting point.

What dose of B12 is needed to correct a deficiency?
Oral doses of at least 1 mg (1,000 mcg) daily are usually needed to rebuild depleted B12 stores, often well above what a standard multivitamin provides, and some people don’t respond well to oral B12 alone even at that dose. Many people benefit from combining a B-complex with a separate high-dose B12 supplement, and sublingual forms tend to replete levels faster than standard capsules. Some individuals with significant deficiency or malabsorption issues may need B12 injections to correct levels effectively.

Is a high vitamin B12 level dangerous?
Not when it comes from supplements or injections. B12 has no tolerable upper intake level because no adverse effects have been tied to high intakes, and the body doesn’t store the excess the way it stores fat-soluble vitamins. An unexplained high level in someone who isn’t supplementing can be a marker of an underlying condition, such as liver or kidney disease, and is worth investigating, but the B12 itself is not toxic.

Related post:Vitamin B12 & Weight Loss: The Metabolic Connection

References
National Institutes of Health, Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals. NIH ODS
The pathophysiology of elevated vitamin B12 in clinical practice. QJM. 2013. PubMed
Serum and cerebrospinal fluid vitamin B12 levels in demented patients with CH3-B12 treatment — preliminary study. PubMed
Pennypacker LC, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992;40(12):1197–1204. PubMed
Letter to the Editor: Reversible dementia with “normal” serum vitamin B12 levels. J Am Geriatr Soc. 1996. DOI
Chandler RJ, Venditti CP. Genetic and genomic systems to study methylmalonic acidemia. PubMed
Wan Ismail WR, et al. MTHFR gene polymorphism and folic acid metabolism. PubMed
Homocysteine Lowering Trialists’ Collaboration. Effects of folic acid supplementation on cardiovascular disease and stroke risk. PubMed
Hou Z, et al. Causal Links Between Gut Microbiota and Vitamin Deficiencies: Evidence from Mendelian Randomization Analysis. PMC